Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

TESARO

Biotech & Life Sciences · Waltham, United States · Founded 2010 · IPO 2012 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$5.10B
Market cap · 2026

Investors

3 investors on TESARO's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
NEA
Series B+ 2 investors entered at this stage
Sofinnova Investments
Kleiner Perkins

Patent intelligence

$39M patent portfolio · 27 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$39M
0.77% of market cap · 3.4× smaller than top peer Deciphera Pharmaceuticals ($133M)
27 active patent families
Where TESARO innovates Cancer researchCarcinosisOncologyMolecular biologyImmunology
Above peer median on Legal, Market

Quality vs same-sector peers

TESARO on the five Patsnap quality dimensions

TESARO in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where TESARO concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across TESARO and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See TESARO on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo